Our clinical trials test new drugs or combinations of drugs in people living with blood cancer.
Research with reason
3rd biggest cancer killer
Blood cancer claims more lives than breast or prostate cancer each year
5th most common cancer
Blood cancer is the 5th most common type of cancer
Life changing results
In 1960 less than 1 in 10 children with acute lymphoblastic leukaemia (ALL) survived - today nearly 8 in 10 do
Funding that matters
You’re helping fund over 400 leading researchers working in over 160 projects across the UK
Latest research from Bloodwise
Our funding schemes
Our schemes include funding for laboratory-based research projects, training and career development awards and clinical trials.
Our funding committees
We have three expert committees, which consider and review grant applications after they've been reviewed by experts around the world.
Find out more about Hodgkin lymphoma in our live chat with Dr Stephen Daw
We’re holding a Q&A about Hodgkin lymphoma with Bloodwise-funded researcher Dr Stephen Daw. Find out more about his research and how you can get involved.
New approach to treating anaemia in blood cancer
Researchers have found that when mistakes happen in a gene responsible for translating DNA to protein, it can lead to the development of a type of blood cancer called myelodysplastic syndrome (MDS). Find out more about this exciting research here.